Kymera Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $19M | 632k | 29.85 |
| 2024-03-31 | $22M | 547k | 40.33 |
| 2023-12-31 | $11M | 441k | 25.33 |
| 2023-09-30 | $4.8M | 339k | 14.00 |
| 2023-06-30 | $9.3M | 406k | 23.00 |
| 2022-12-31 | $5.9M | 238k | 24.97 |
| 2022-06-30 | $6.6M | 334k | 19.82 |
| 2022-03-31 | $7.9M | 186k | 42.32 |
| 2021-06-30 | $3.1M | 64k | 48.52 |
| 2020-12-31 | $1.1M | 18k | 62.00 |
| 2020-09-30 | $0 | 4.6k | 0.00 |